Stock 6817 WINSTON MEDICAL SUPPLY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Winston Medical Supply Co., Ltd.

Equities

6817

TW0006817000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 10/05/2024 am IST 		5-day change 1st Jan Change
129.5 TWD -2.63% Intraday chart for Winston Medical Supply Co., Ltd. +1.97% +31.87%
25/03 Winston Medical Supply Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Winston Medical Supply Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 1,368 1,138 1,809
Enterprise Value (EV) 1 1,273 997.6 1,573
P/E ratio 15.1 x 10.3 x 11.4 x
Yield 5.31% 8.09% 6.72%
Capitalization / Revenue 2.55 x 1.88 x 2.55 x
EV / Revenue 2.37 x 1.64 x 2.22 x
EV / EBITDA 8.53 x 5.87 x 7.04 x
EV / FCF 11.9 x 10.7 x 9.95 x
FCF Yield 8.41% 9.32% 10%
Price to Book 4.26 x 3.15 x 4.23 x
Nbr of stocks (in thousands) 18,167 18,417 18,417
Reference price 2 75.30 61.80 98.20
Announcement Date 16/06/22 21/04/23 25/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 342.4 364.9 505.1 536.5 606.5 709.1
EBITDA 1 10.76 26.55 118.2 149.3 170 223.6
EBIT 1 -28.17 -8.254 83.72 115.3 135.9 196.1
Operating Margin -8.23% -2.26% 16.57% 21.49% 22.4% 27.66%
Earnings before Tax (EBT) 1 -28.62 -8.544 85.75 116.6 141.4 198.8
Net income 1 -25.95 -9.358 99.68 92.13 111.3 158.8
Net margin -7.58% -2.56% 19.73% 17.17% 18.34% 22.39%
EPS 2 -1.483 -0.5347 5.620 4.990 6.010 8.580
Free Cash Flow 1 9.842 48.6 74.48 107.1 92.98 158.1
FCF margin 2.87% 13.32% 14.74% 19.96% 15.33% 22.29%
FCF Conversion (EBITDA) 91.46% 183.05% 63.01% 71.73% 54.69% 70.69%
FCF Conversion (Net income) - - 74.71% 116.25% 83.57% 99.56%
Dividend per Share - - 3.000 4.000 5.000 6.600
Announcement Date 25/11/20 25/11/20 21/04/21 16/06/22 21/04/23 25/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 163 122 - - - -
Net Cash position 1 - - 7 94.7 141 235
Leverage (Debt/EBITDA) 15.11 x 4.578 x - - - -
Free Cash Flow 1 9.84 48.6 74.5 107 93 158
ROE (net income / shareholders' equity) -15.9% -5.27% 43.7% 30.3% 32.4% 40.2%
ROA (Net income/ Total Assets) -2.65% -0.84% 8.22% 11.1% 12.7% 16.3%
Assets 1 979.7 1,117 1,213 828.1 876.5 973.6
Book Value Per Share 2 10.40 9.870 16.20 17.70 19.60 23.20
Cash Flow per Share 2 6.070 6.940 8.360 8.840 11.00 16.20
Capex 1 12.7 6.46 2.9 5.05 6.39 19
Capex / Sales 3.7% 1.77% 0.57% 0.94% 1.05% 2.68%
Announcement Date 25/11/20 25/11/20 21/04/21 16/06/22 21/04/23 25/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
WINSTON MEDICAL SUPPLY CO., LTD. Stock Winston Medical Supply Co., Ltd.
+31.87% 73.47M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.27B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.52% 22.92B
SANDOZ GROUP AG Stock Sandoz Group AG
+20.29% 15.43B
CIPLA LIMITED Stock Cipla Limited
+7.48% 12.95B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+42.51% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.84% 6.91B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.13% 5.55B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6817 Stock
  4. Financials Winston Medical Supply Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW